Cargando…
Engineering enzymatic assembly lines to produce new antibiotics
Numerous important therapeutic agents, including widely-used antibiotics, anti-cancer drugs, immunosuppressants, agrochemicals and other valuable compounds, are produced by microorganisms. Many of these are biosynthesised by modular enzymatic assembly line polyketide synthases, non-ribosomal peptide...
Autores principales: | Bozhüyük, Kenan AJ, Micklefield, Jason, Wilkinson, Barrie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Current Biology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908967/ https://www.ncbi.nlm.nih.gov/pubmed/31743841 http://dx.doi.org/10.1016/j.mib.2019.10.007 |
Ejemplares similares
-
Bifurcation drives the evolution of assembly-line biosynthesis
por: Booth, Thomas J., et al.
Publicado: (2022) -
Gene editing enables rapid engineering of complex antibiotic assembly lines
por: Thong, Wei Li, et al.
Publicado: (2021) -
Genome editing reveals that pSCL4 is required for chromosome linearity in Streptomyces clavuligerus
por: Gomez-Escribano, Juan Pablo, et al.
Publicado: (2021) -
Enzymatic Enantioselective Decarboxylative Protonation of Heteroaryl Malonates
por: Lewin, Ross, et al.
Publicado: (2015) -
Engineered biosynthesis of enduracidin lipoglycopeptide antibiotics using the ramoplanin mannosyltransferase Ram29
por: Wu, Ming-Cheng, et al.
Publicado: (2015)